六例遗传性易栓症的血栓发生与实验表型及基因型关联分析
摘要
易栓症包括遗传性和获得性。获得性易栓症继发于手术创伤、制动、口服避孕药、母体免疫性疾病、恶性肿瘤等,遗传性易栓症主要是由蛋白c(Pc)、蛋白s(Ps)和抗凝血酶(AT)缺陷导致。AT缺陷的发病率为1/5000—1/500,病情较为严重。遗传性Pc缺陷为常染色体显性遗传病,
出处
《中华血液学杂志》
CAS
CSCD
北大核心
2013年第3期256-258,共3页
Chinese Journal of Hematology
参考文献12
-
1傅启华,许先国,丁秋兰,胡翊群,王学锋,王鸿利.抗凝血酶基因13389G缺失导致的Ⅰ型抗凝血酶缺乏症[J].中华血液学杂志,2002,23(11):588-590. 被引量:26
-
2Labrouche S, Reboul MP, Gu6rin V, et al. Protein C and protein S assessment in hospital laboratories: which strategy and what role for DNA sequencing?. Blood Coagul Fibrinolysis, 2003, 14: 531- 538.
-
3Hiyoshi M, Arnutti P, Prayoonwiwat W, et al. A polymorphism nt 1628G---+A(R485K) in exon 10 of the coagulation factor V gene may be a risk factor for thrombosis in the indigenous Thai popula- tion. Thromb Haemost, 1998, 80: 705-706.
-
4Reitsma PH, Bernardi F, Doig RG, et al. Protein C deficiency: a database of mutations, 1995 update. On behalf of the Subcommit- tee on Plasma Coagulation Inhibitors of the Scientific and Standard- ization Committee of the ISTH. Thromb Haenmst, 1995, 73: 876- 889.
-
5Allaart CF, Aronson DC, Ruys T, et al. Hereditary protein S defi- ciency in young adults with arterial occlusive disease. Thromb Hae- most, 1990, 64: 206-210.
-
6Le W, Yu JD, Lu L, et al. Association of the R485K polymor- phism of the factor V gene with poor response to activated protein C and increased risk of coronary artery disease in the Chinese pop- ulation. Clin Genet, 2000,57 : 296-303.
-
7Lee W, Yue P, Zhang Z. Analytical methods for inferring func- tional effects of single base pair substitutions in human cancers. Hum Genet, 2009, 126: 481-498.
-
8Fernandez JA, Griffin JH. A protein S binding site on C4b-binding protein involves beta chain residues 31-45. J Biol Chem, 1994, 269:2535-2540.
-
9O' Donnell J, Tuddenham EG, Manning R, et al. High preva- lence of elevated factor V$ levels in patients referred for thrombo- philia screening: role of increased synthesis and relationship to the acute phase reaction. Thromb Haemost, 1997, 77:825-828.
-
10潘学谊,丁彩屏,商谊,黄旭明,郭煜,尹金柱,蔡小燕,张柔玲.部分血浆凝血因子活性测定在急性缺血性脑卒中的临床意义[J].中华血液学杂志,2003,24(9):495-496. 被引量:2
二级参考文献8
-
1许建平 刘泽霖 贺石林 李家增 主编.病因与发病机制[A].刘泽霖,贺石林,李家增,主编.血栓性疾病的诊断与治疗[C].北京:人民卫生出版社,2000.18-25.
-
2Kraaijenhagen RA, in' t Anker PS, Koopman MM, et al. High plasma concentration factor Ⅷ c is a major risk factor for venous thromboembolism. Thromb Haemost,2000,83:5-9.
-
3Koster T, Blann AD, Briet E,et al. Role of coltting factor Ⅷ in effect of von Willebrand factor an occurrence of deep-vein thrombosis. Lancet,1995, 545:152-155.
-
4Smith FB, Lee AJ, Fowkes FG, et al. Hemostatic factor as predictors of ischemic heart disease and stroke in the Edinburgh Artery Study. Arterioscler Thromb Vasc Biol, 1997, 17:3321-3325.
-
5Folsom AR, Rosamond WD, Shahar E, et al. Prospective study of markers of hemostatic function with risk of ischemic stroke. Circulation, 1999,100 : 736-742.
-
6Kario K. Matsuo T, Miyata T. Activated factor Ⅶ as new cardiovascular risk factor of atherothrombotic disease. Rinsho Byori, 1995,43: 1201-1208.
-
7Meijers JCM, Tekelenburg WLH, Bouma BN, et al. High levels of coagulation factor Ⅺ as a risk factor for venous thrombosis. N Engl J Med,2000,342: 696-701.
-
8Guido Finazzi MD. The epidemiology of the antiphospholipid syndrome: Who is at risk?[J] 2001,Current Rheumatology Reports(4):271~276
共引文献35
-
1傅启华,王文斌,丁秋兰,周荣富,武文漫,胡翊群,王学锋,严力行,王振义,王鸿利.AT基因13387-9delG突变引起遗传性抗凝血酶缺陷症的分子病理机制研究[J].中国实验诊断学,2004,8(5):462-465. 被引量:2
-
2周红.抗磷脂抗体与血栓形成[J].江苏大学学报(医学版),2004,14(5):445-448. 被引量:6
-
3陈阿琴.自身免疫病患者血清中抗β_2糖蛋白Ⅰ抗体的检测[J].江苏大学学报(医学版),2005,15(1):67-68. 被引量:4
-
4傅启华,王文斌,丁秋兰,周荣富,武文漫,胡翊群,王学锋,严力行,王振义,王鸿利.抗凝血酶基因C2759T(Leu99Phe)突变导致抗凝血酶缺陷症的分子机制研究[J].中华血液学杂志,2005,26(3):148-151. 被引量:9
-
5周荣富,戴菁,傅启华,王文斌,谢爽,丁秋兰,胡翊群,王学锋,王鸿利.抗凝血酶基因C2757T杂合突变致Ⅰ型遗传性抗凝血酶缺陷症[J].中华医学杂志,2005,85(23):1640-1642. 被引量:13
-
6陈巧林,周红,解冰,谭魁林,许文荣,单玉容.抗β_2-GPI抗体与狼疮性肾炎的相关性研究[J].临床检验杂志,2005,23(3):217-218.
-
7周荣富,时国朝,傅启华,王文斌,谢爽,戴菁,丁秋兰,胡翊群,王学锋,邓伟吾,王鸿利.抗凝血酶基因G13328A杂合突变导致血栓形成[J].中华血液学杂志,2005,26(11):661-664. 被引量:9
-
8单玉蓉,周红,陈巧林.抗β_2-糖蛋白1抗体与狼疮性肾炎的关系研究[J].现代检验医学杂志,2005,20(6):37-38. 被引量:2
-
9张付华,吴竞生.遗传性抗凝血酶缺乏症研究进展[J].血栓与止血学,2005,11(6):284-286. 被引量:4
-
10杨芳,王冠军,李薇,王学锋,丁秋兰,王鸿利.抗凝血酶基因A9850G突变导致一个新的遗传性抗凝血酶缺陷症家系[J].检验医学,2006,21(1):18-21. 被引量:7
-
1汪丽萍,余艳红.获得性易栓症对母婴不良结局的影响[J].实用妇产科杂志,2009,25(3):136-138. 被引量:17
-
2邹虹,漆洪波.遗传性易栓症的研究进展[J].中华产科急救电子杂志,2014,3(2):59-62. 被引量:9
-
3马艳春.妊娠期高血压疾病与妊娠结局关联分析[J].心血管病防治知识(学术版),2015,5(11):30-32. 被引量:2
-
4霍梅,刘妹,周莉.妊娠晚期孕妇抗凝与纤溶活性检测的临床意义[J].中国妇幼保健,2009,24(5):610-611.
-
5王雅楠,杨孜.妊娠期易栓症并发症的预防[J].实用妇产科杂志,2009,25(3):140-142. 被引量:5
-
6刘娜娜,王树玉.遗传性易栓症与妊娠相关疾病[J].中国优生与遗传杂志,2006,14(7):123-124. 被引量:1
-
7阮焱,张为远.遗传性易栓症对母婴不良结局的影响[J].实用妇产科杂志,2009,25(3):134-136. 被引量:3
-
8任国春,刘翠阳,隋鑫.子宫内膜异位症手术及药物的现代联合治疗[J].齐齐哈尔医学院学报,2007,28(9):1070-1071.
-
9涂姝,黄仲委,余杨桂.Axenfeld—Rieger综合征一例[J].中华眼科杂志,2008,44(11):1042-1043. 被引量:1
-
10马红梅,丁雁,王宇.药物治疗子宫内膜异位症的进展[J].西南国防医药,2008,18(5):771-773. 被引量:2